logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Topoisomerase Inhibitor class drugs

    FiltersReset Filters
    6 results

    • etopophos

      (etoposide phosphate)
      H2-Pharma, LLC
      Usage: ETOPOPHOS is indicated for use in combination with other chemotherapeutic agents to treat refractory testicular tumors and, alongside cisplatin, for the first-line treatment of small cell lung cancer.

    • etoposide

      (Etoposide)
      Meitheal Pharmaceuticals Inc.
      Usage: Etoposide Injection is indicated for managing refractory testicular tumors and as a first-line treatment for small cell lung cancer, used in combination with other approved chemotherapy agents following appropriate surgical and therapeutic interventions.

    • irinotecan hydrochloride

      (Irinotecan Hydrochloride)
      Ingenus Pharmaceuticals, LLC
      Usage: Irinotecan hydrochloride injection is indicated for first-line therapy, in combination with 5-fluorouracil and leucovorin, for metastatic colon or rectum carcinoma. It is also used for patients whose disease has recurred or progressed after initial fluorouracil-based therapy.

    • onivyde

      (IRINOTECAN HYDROCHLORIDE)
      Ipsen Biopharmaceuticals, Inc.
      Usage: ONIVYDE is indicated for use in combination with other medications for treating metastatic pancreatic adenocarcinoma in adults, both as a first-line treatment and after progression on gemcitabine-based therapy. It is not approved as a standalone treatment for this condition.

    • topotecan

      (Topotecan)
      Accord Healthcare Inc.
      Usage: Topotecan Injection is indicated for treating sensitive small cell lung cancer after first-line chemotherapy failure and, in combination with cisplatin, for stage IV-B, recurrent, or persistent cervical carcinoma not suitable for curative surgery or radiation therapy.

    • topotecan hydrochloride

      (TOPOTECAN HYDROCHLORIDE)
      Fresenius Kabi USA, LLC
      Usage: Topotecan hydrochloride is indicated for treating metastatic ovarian cancer after chemotherapy progression, small cell lung cancer in platinum-sensitive patients post-first-line treatment progression, and Stage IV-B cervical cancer in combination with cisplatin, for patients not eligible for curative treatment.